ArticleJournal of thoracic disease2026
Clinical characteristics and surgical outcomes of uniportal video-assisted thoracoscopic surgery for lung cancer patients with concomitant pulmonary tuberculosis: a retrospective cohort study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The coexistence of lung cancer and pulmonary tuberculosis (TB) presents substantial surgical challenges. This study aimed to analyze the clinical characteristics and evaluate the surgical outcomes of uniportal video-assisted thoracoscopic surgery (U-VATS) in lung cancer patients with concomitant pulmonary TB compared with those without TB. Methods: This retrospective cohort study reviewed medical records of patients who underwent U-VATS for primary lung cancer between January 2020 and October 2025. Patients were categorized into the tuberculosis group (lung cancer with concomitant pulmonary TB, n=106) and the control group (lung cancer without tuberculosis, n=104). Baseline demographics, clinical characteristics, intraoperative parameters, postoperative recovery indices, complications, and short-term oncological outcomes were compared. Continuous variables were analyzed using Student's t-test or the Mann-Whitney U test, and categorical variables were compared using the Chi-squared test or Fisher's exact test where appropriate. Results: A total of 210 patients were enrolled. No significant differences were observed in age, sex distribution, or tumor size between groups. The tuberculosis group exhibited a higher proportion of upper lobe lesions (64.2% Conclusions: U-VATS is technically feasible and oncologically safe for lung cancer patients with concomitant pulmonary TB, despite increased operative complexity manifested by prolonged surgical time and extended postoperative recovery. Meticulous preoperative evaluation and experienced surgical technique are essential for optimal outcomes in this challenging patient population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.